From the Center
AllSides Media Bias Rating: Center
The U.S. government has awarded $176 million to Moderna (MRNA.O), opens new tab to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.
Shares of the Cambridge, Massachusetts-based company rose more than 2% to $118.32 in early trade.
The funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza, the company said in a statement.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Youth Voices
State Mandates Capping Insulin Costs: A Help or Hindrance?
The Alliance for Civic Engagement
June 15th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
